Agile Therapeutics, Inc. (AGRX)

Agile Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	10	4	5	1	243	124
Market Cap Growth	-87.76%	-14.27%	314.23%	-99.51%	96.66%	525.25%
Enterprise Value	7	4	2	-0	245	89
PE Ratio	-	-0.29	-0.19	-0.02	-4.44	-6.70
PS Ratio	0.45	0.21	0.45	0.29	324.48	-
PB Ratio	-0.12	-0.26	-0.88	0.13	4.93	2.70
P/FCF Ratio	-0.12	-0.44	-0.14	-0.02	-5.10	-7.83
P/OCF Ratio	-0.12	-0.44	-0.14	-0.02	-5.14	-7.88
EV/Sales Ratio	0.35	0.19	0.17	-0.04	327.23	-
EV/EBITDA Ratio	0.06	-0.20	-0.05	0.00	-5.03	-4.80
EV/EBIT Ratio	0.06	-0.19	-0.04	0.00	-5.00	-4.76
EV/FCF Ratio	0.09	-0.40	-0.05	0.00	-5.14	-5.65
Debt / Equity Ratio	-0.04	-0.13	-0.40	1.92	0.33	0.00
Debt / EBITDA Ratio	-0.02	-0.11	-0.05	-0.25	-0.34	-0.01
Debt / FCF Ratio	-0.04	-0.23	-0.06	-0.27	-0.35	-0.01
Quick Ratio	0.35	0.29	0.64	0.71	7.53	9.09
Current Ratio	0.56	0.46	0.85	0.82	7.72	9.31
Asset Turnover	1.86	1.91	0.76	0.10	0.01	0
Interest Coverage	-14.90	-14.01	-13.23	-18.14	-15.78	0
Return on Equity (ROE)	75.49%	88.64%	458.29%	-826.07%	-110.86%	-40.32%
Return on Assets (ROA)	-61.81%	-141.05%	-178.43%	-194.71%	-74.85%	-37.23%
Return on Capital (ROIC)	160.22%	140.56%	1242.77%	-262.37%	-74.50%	-41.07%
Earnings Yield	-80.62%	-343.94%	-518.01%	-6466.75%	-22.50%	-14.92%
FCF Yield	-108.18%	-227.72%	-735.47%	-5528.30%	-19.61%	-12.77%
Buyback Yield / Dilution	-407.86%	-398.99%	-35520.10%	97.13%	-71.31%	-44.06%
Total Shareholder Return	-407.86%	-398.99%	-35520.10%	97.13%	-71.31%	-44.06%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.